IESE (España)
-
The Shubert Organization: The Show Must Go On (condensed)
Beech, María Alejandra; Villanueva, Julian; González, JorgeCase M-1240-EMarketingIn January 2009, Bob Wankel sat in his office at the historic Sardi's building on 44th Street, New York, as he considered the challenges ahead: several Broadway shows were closing, and a severe economic downturn threatened future productions. Many were calling for changes in the theater industry, and the Shubert Organization (where Mr. Wankel had worked for 33 years) had recently lost its Chairman, Gerald Schoenfeld. As the firm's new President a...Starting at €8.20
-
A Walk Through the United States
Bardolet Urgellès, David; Baucells Alibés, Manel; Ariño, Miguel AngelCase AD-374-EDecision Analysis, EconomicsThe case presents the well-known traveling salesman problem in the context of having to visit 48 U.S. State Capitals.Starting at €8.20
-
Shubert Organization: el espectáculo debe continuar (condensado)
Beech, María Alejandra; Villanueva, Julian; González, JorgeCase M-1240MarketingEn enero de 2009, Bob Wankel estaba sentado en su despacho, situado en el histórico edificio Sardi's de la calle 44 de Nueva York, pensando en los retos que tenía por delante: varios espectáculos de Broadway se estaban clausurando y una severa recesión económica amenazaba las futuras producciones. Muchas voces estaban pidiendo cambios en el sector teatral, y la Shubert Organization -en la que el Sr. Wankel llevaba 33 años trabajando- había perdi...Starting at €8.20
-
Un paseo por Estados Unidos
Bardolet Urgellès, David; Baucells Alibés, Manel; Ariño, Miguel AngelCase AD-374Decision Analysis, EconomicsEl caso presenta el bien conocido problema del representante en el contexto de visitar 48 ciudades de Estados Unidos.Starting at €8.20
-
Glaxo: The acquisition of Wellcome
Canals, Jordi; Bardolet Urgellès, DavidCase ASE-386-EEconomicsThis case describes the changes in the world pharmaceutical industry in 1995 and presents the challenges for Glaxo (the leading European pharmaceutical firm) and the potential acquisition of Wellcome. This decision will differ from other acquisitions made by firms like Merck, oriented towards vertical integration and control over the distribution network. The main topics that the case covers are: industry analysis; value chain analysis; positioni...Starting at €8.20